Anhui Anke Biotechnology (Group) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000GY2
CNY
9.74
0.11 (1.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
658.11
623.26
609.70
617.51
637.01
650.48
836.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
658.11
623.26
609.70
617.51
637.01
650.48
836.86
Raw Material Cost
170.05
155.49
156.51
155.79
145.29
158.82
192.02
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.59
0.57
0.32
0.64
0.57
0.87
0.63
Selling and Distribution Expenses
253.87
203.66
294.44
219.12
235.82
212.78
389.22
Other Expenses
5.82
3.02
7.00
4.41
4.12
3.39
9.86
Total Expenditure (Excl Depreciation)
482.70
389.94
521.24
419.66
422.92
406.37
680.52
Operating Profit (PBDIT) excl Other Income
175.39999999999998
233.29999999999998
88.5
197.8
214.1
244.1
156.3
Other Income
15.21
20.35
22.11
17.31
29.71
16.27
29.00
Operating Profit (PBDIT)
218.94
285.09
134.78
246.86
273.88
290.68
195.42
Interest
0.59
0.57
0.32
0.64
0.57
0.87
0.63
Exceptional Items
-0.01
-0.98
13.08
-3.78
-2.29
3.50
-2.92
Gross Profit (PBDT)
488.06
467.76
453.19
461.71
491.72
491.66
644.84
Depreciation
31.42
31.42
31.70
31.70
30.38
30.38
27.55
Profit Before Tax
186.92
252.12
115.85
210.74
240.65
262.93
164.32
Tax
22.98
34.55
-11.18
30.11
32.57
35.68
-41.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
157.51
209.00
117.23
173.59
198.38
217.75
192.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
157.51
209.00
117.23
173.59
198.38
217.75
192.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.72
4.31
-1.31
2.56
3.45
4.19
1.15
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
161.24
213.31
115.92
176.14
201.83
221.94
193.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,970.43
4,085.10
4,124.31
3,937.69
3,750.25
3,966.40
3,737.40
Earnings per share (EPS)
0.1
0.13
0.07
0.11
0.12
0.13
0.12
Diluted Earnings per share
0.1
0.13
0.07
0.11
0.12
0.13
0.12
Operating Profit Margin (Excl OI)
26.18%
37.44%
13.28%
32.04%
33.56%
37.52%
16.59%
Gross Profit Margin
33.18%
45.49%
24.2%
39.26%
42.55%
45.09%
22.93%
PAT Margin
23.93%
33.53%
19.23%
28.11%
31.14%
33.48%
23.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.58% vs 2.23% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -24.43% vs 84.04% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -23.04% vs 134.87% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 100.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Anhui Anke Biotechnology (Group) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
658.11
0
658.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
658.11
0
658.11
Raw Material Cost
170.05
0
170.05
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.59
0
0.59
Selling and Distribution Expenses
253.87
0
253.87
Other Expenses
5.82
0.00
5.82
Total Expenditure (Excl Depreciation)
482.70
0
482.70
Operating Profit (PBDIT) excl Other Income
175.41
0.00
175.41
Other Income
15.21
0
15.21
Operating Profit (PBDIT)
218.94
0
218.94
Interest
0.59
0
0.59
Exceptional Items
-0.01
0
-0.01
Gross Profit (PBDT)
488.06
0
488.06
Depreciation
31.42
0
31.42
Profit Before Tax
186.92
0
186.92
Tax
22.98
0
22.98
Provisions and contingencies
0
0
0.00
Profit After Tax
157.51
0
157.51
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
157.51
0
157.51
Share in Profit of Associates
0
0
0.00
Minority Interest
3.72
0
3.72
Other related items
0.00
0.00
0.00
Consolidated Net Profit
161.24
0
161.24
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,970.43
0
3,970.43
Earnings per share (EPS)
0.10
0
0.10
Diluted Earnings per share
0.10
0
0.10
Operating Profit Margin (Excl OI)
26.18%
0%
0.00
26.18%
Gross Profit Margin
33.18%
0%
0.00
33.18%
PAT Margin
23.93%
0%
0.00
23.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 65.81 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.58% vs 2.23% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.31% vs -7.26% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.12 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -24.43% vs 84.04% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -20.12% vs -5.26% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.37 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -23.04% vs 134.87% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -16.58% vs -8.33% in Jun 2024

Quarterly - Interest
Interest 0.06 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 100.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs 50.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.18%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024